The postdoctoral Training Program in Endocrinology at the Massachusetts General Hospital provides intensive research experience in basic or clinical investigation, complemented by a didactic component appropriate to the training goals. The trainees are primarily MDs and MD/PhDs who desire careers in investigative endocrinology and academic medicine, as well as PhDs who want further research training. The trainees are selected from a large applicant pool on the basis of prior academic and/or research achievement and evidence of strong commitment to a career in biomedical investigation. The Program Director (K. Miller) and the Associate Director (J. Florez) are senior Physician-Scientists who govern in conjunction with the Endocrine Division Education Council, a committee of experienced endocrine scientists. The faculty consists of 42 active, well-funded scientists, whose interests range broadly across the subdisciplines of endocrinology and from clinical, bedside investigation to genetic and molecular mechanisms. The trainees are supervised closely by a primary faculty mentor, and interact extensively with junior faculty, who often serve as co-mentors. In addition, individual Scientific Advisory Committees provide ongoing scientific and career counsel. Internal and External Advisory Committees provide evaluation and recommendations for Program improvement. Formal Program and Mentorship trainee surveys and frequent (at least twice annual) one-on-one meetings between the Program Director and trainees provide specific actionable input re: the Program and mentorship. An extensive program of didactic sessions complements the research activity. This includes several weekly scientific series, including Endocrine Grand Rounds, and a monthly Career Development didactic series designed for the Training Grant trainees specifically. The productivity of past trainees during training has been very high overall, as judged by the number and quality of trainee publications, number of trainees who obtain subsequent grants and percent who remain in academia and the biotechnology/pharmaceutical industry. The facilities at the MGH and Harvard Medical School are extensive, including a Division of Clinical Research, Harvard Catalyst Clinical and Translational Science Center (CTSC) program and over 50,000 square feet of modern laboratories dedicated to endocrine training faculty. This training grant is the central stabilizing financial element in this program and is critical in enabling MD and MD/PhD trainees to achieve careers in biomedical investigation.

Public Health Relevance

The Training Program in Endocrinology at Massachusetts General Hospital (MGH)?s goal is to train MD, and MD-PhD physician scientists and PhD scientists in clinical and/or laboratory research related to endocrinology, diabetes, metabolism and allied fields. The public health burden of endocrine diseases (such as diabetes and its complications, obesity and osteoporosis) and its associated societal costs are enormous, and therefore there is an urgent need to train and enable the best and brightest individuals considering careers in biomedical investigation to deploy contemporary experimental methods that will generate insights into this set of disorders, elucidate their pathophysiology, and illuminate potential avenues for treatment. With these goals in mind, the MGH Training Program in Endocrinology has produced a large number of endocrine investigators over the years, many of whom have become authentic leaders in science, academia and industry.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
2T32DK007028-46
Application #
9935193
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1975-07-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
46
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Yang, Xuehui; Gong, Yan; He, Qing et al. (2018) Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. J Cell Biochem 119:3267-3279
Dichtel, Laura E; Lawson, Elizabeth A; Schorr, Melanie et al. (2018) Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum. Neuropsychopharmacology 43:1436-1444
Foldyna, Borek; Fourman, Lindsay T; Lu, Michael T et al. (2018) Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr 78:421-428
Cheru, Lediya T; Fitch, Kathleen V; Saylor, Charles F et al. (2018) Mild renal impairment is associated with calcified plaque parameters assessed by CT angiography in people living with HIV. AIDS :
Lubitz, Carrie C; Zhan, Tiannan; Gunda, Viswanath et al. (2018) Circulating BRAFV600E Levels Correlate with Treatment in Patients with Thyroid Carcinoma. Thyroid 28:328-339
Hong, Jaeyoung; Hatchell, Kathryn E; Bradfield, Jonathan P et al. (2018) Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations. J Clin Endocrinol Metab 103:1380-1392
Rosenbaum, Matthew W; Gigliotti, Benjamin J; Pai, Sara I et al. (2018) PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma. Endocr Pathol 29:59-67
Gogia, Shawnbir; Coromilas, Alexandra; Regan, Susan et al. (2018) Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database Study. J Acquir Immune Defic Syndr 79:e39-e41
Cheru, Lediya T; Park, Elli A; Saylor, Charles F et al. (2018) I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV. Open Forum Infect Dis 5:ofy288
Chan, Yee-Ming; Lippincott, Margaret F; Kusa, Temitope O et al. (2018) Divergent responses to kisspeptin in children with delayed puberty. JCI Insight 3:

Showing the most recent 10 out of 169 publications